Abstract:The RNA interference (RNAi) pathway has evolved numerous functionalities in eukaryotes, with many on display in Kingdom Fungi. RNAi can regulate gene expression, facilitate drug resistance, or even be altogether lost to improve growth potential in some fungal pathogens. In the WHO fungal priority pathogen, Aspergillus fumigatus, the RNAi system is known to be intact and functional. To extend our limited understanding of A. fumigatus RNAi, we first investigated the genetic variation in RNAi-associated genes in a collection of 217 environmental and 83 clinical genomes, where we found that RNAi components are conserved even in clinical strains. Using endogenously expressed inverted-repeat transgenes complementary to a conditionally essential gene (pabA) or a nonessential gene (pksP), we determined that a subset of the RNAi componentry is active in inverted-repeat transgene silencing in conidia and mycelium. Analysis of mRNA-seq data from RNAi double-knockout strains linked the A. fumigatus dicer-like enzymes (DclA/B) and RNA-dependent RNA polymerases (RrpA/B) to regulation of conidial ribosome biogenesis genes; however, surprisingly few endogenous small RNAs were identified in conidia that could explain this broad change. Although RNAi was not clearly linked to growth or stress response defects in the RNAi knockouts, serial passaging of RNAi knockout strains for six generations resulted in lineages with diminished spore production over time, indicating that loss of RNAi can exert a fitness cost on the fungus. Cumulatively, A. fumigatus RNAi appears to play an active role in defense against double-stranded RNA species alongside a previously unappreciated housekeeping function in regulation of conidial ribosomal biogenesis genes.

RNAi technology: A Novel approaches against fungal infections

RNA Interference Strategies for Future Management of Plant Pathogenic Fungi: Prospects and Challenges

RNA as a drug target.

RNAi: antifungal therapy against Invasive pulmonary aspergillosis (IPA) in humans

RNA-based Therapeutics: an Overview and Prospectus

Concepts and considerations for enhancing RNAi efficiency in phytopathogenic fungi for RNAi-based crop protection using nanocarrier-mediated dsRNA delivery systems

The Key Role of RNA Interference

RNA interference: a promising biotechnological approach to combat plant pathogens, mechanism and future prospects

Inhibition of Bacterial RNA Polymerase Function and Protein-Protein Interactions: A Promising Approach for Next-Generation Antibacterial Therapeutics

[New Inhibitors Targeting Bacterial RNA Polymerase].

RNA-Based Control of Fungal Pathogens in Plants

Advances in RNA therapeutics for modulation of 'undruggable' targets

RNAi-biofungicides: a quantum leap for tree fungal pathogen management

New Insights on the Integrated Management of Plant Diseases by RNA Strategies: Mycoviruses and RNA Interference

Antiviral RNAi therapy: emerging approaches for hitting a moving target

Disruption of the Aspergillus fumigatus RNA interference machinery alters the conidial transcriptome

Exploiting RNA Interference Mechanism in Plants for Disease Resistance

The RNAi as a tool to control tropical pathogens

RNAi function, diversity, and loss in the fungal kingdom

Bioinformatics Approaches in the Development of Antifungal Therapeutics and Vaccines

Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond.